Related topics: clinical trials

Researchers develop a safer carrier for cancer vaccines

Lipid nanoparticle (LNP)-based messenger ribonucleic acid (mRNA) vaccines have recently emerged as a promising strategy for the prevention and treatment of cancers, as well as infectious diseases. LNPs are carriers that safely ...

page 1 from 3